Iron therapy is a medical treatment used to correct severe iron deficiency when it cannot be managed through diet or regular ...

Iron-rich foods are an essential part of any balanced diet. Know which foods are high in iron so you can add them to your favorite recipes.

Use of erythropoiesis-stimulating agents (ESAs) was associated with an increased risk for cancer in patients undergoing dialysis, according to a new study based on data from nearly 9800 individuals.

“Iron deficiency anemia is a global health issue with significant effects on quality of life and productivity,” notes Dr. Wendy Lim, hematologist and professor in the Department of Medicine at ...

In a phase 3 trial, oral ferric citrate effectively raised hemoglobin and improved iron parameters in Taiwanese patients with iron deficiency anemia over 16 weeks. Ferric citrate significantly ...

Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...

Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.

Elizabeth Barnes, MS, RDN, LDN, is a dietitian with a focus on treating clients with eating disorders and disordered eating to help them to mend their relationship with food and their bodies. Fatigue, ...

IV iron dextran was the most cost-effective treatment, yielding 19.26 quality-adjusted life years at a cost of $157,500 vs 19.10 costing $152,900 for oral ferrous sulfate. HealthDay News — Intravenous ...

The researchers noted that "altered iron metabolism may represent a potentially modifiable systemic correlate of the AD phenotypes." HealthDay News — Iron deficiency without anemia is a common feature ...

Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients. Małgorzata Ponikowska, from Wroclaw Medical University in ...

Findings from the FORTIS trial showed the mean change in hemoglobin at week 12 was 1.10 g/dL. The Food and Drug Administration (FDA) has expanded the approval of Accrufer® (ferric maltol) to include ...